Acrux is a dynamic Australian drug delivery business developing and commercialising a range of patient-preferred pharmaceutical products for global markets, using innovative, patented technology to administer drugs to humans and animals.
Acrux Limited is a Pooled Development Fund. Shareholders will be entitled to concessionary tax treatment in Australia for income and capital gains derived in connection with their shareholding. Non–residents will not be subject to withholding tax on dividends paid. A shareholder or potential Shareholder should obtain their own tax advice rather than relying on this summary.
Learn more about Acrux
Learn more about our history
Acrux is listed on the Australian Securities Exchange (ASX code: ACR).
View Share Price Information
View Announcements & Reports
Ross Dobinson — Non-Executive Chairman
Bruce Parncutt — Non-Executive Director
Geoff Brooke — Non-Executive Director
Tim Oldham — Non-Executive Director
Michael Kotsanis — CEO & Managing Director
Simon Green — Non-Executive Director
Bruce Parncutt — Chair, Audit and Risk Committee
Tim Oldham — Chair, Human Capital Committee
Tim Bateman — CFO & Company Secretary
103-113 Stanley Street West Melbourne VIC 3003 Australia
Link Market Services
Level 1, 333 Collins Street
MELBOURNE VIC 3000
Locked Bag A14, Sydney South, NSW 1235
Toll-free: 1300 554 474 (Australia only)
International: +61 1300 554 474
Facsimile: (02) 9287 0303
Facsimile: (02) 9287 0309 (for proxy voting)
Level 19, 15 William St.
Melbourne VIC 3000
Telephone: +61 3 8610 5000
Facsimile: +61 3 8610 5999